Accuracy of an Echo-Stress Protocol Using Regadenoson With Speckle Tracking
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 161 participants.
Also called NCT02130453
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; single masking; primary purpose diagnostic
- Phase
- Phase 4
- Enrolled
- 161 participants
- Sponsor
- M.D. Anderson Cancer Center
- Registry
-
NCT02130453
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT02130453. Non-randomized; single masking; primary purpose diagnostic. Start 2014-09-30 (actual); primary completion 2024-06-28 (actual). Results posted on 2024-10-02.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Accuracy of an Echo-Stress Protocol Using Regadenoson With Speckle Tracking
- Condition
- Ischemia
- Intervention (Drug)
- Regadenoson
- Lead sponsor
- M.D. Anderson Cancer Center
- Collaborator
- Astellas Scientific & Medical Affairs, Inc.
Record details
- Record id
cardio:ct-nct02130453- Content hash
26bd3eff465d4cd858748f7a80f1206eca3fe368cc91d280809764b7a49641ff